Mary-Dell Chilton

Mary-Dell Chilton had journeyed from the West Coast to New York City in September 1977 to demonstrate her discovery to one of the most important plant scientists in the world, Armin Braun, a professor at Rockefeller University. Braun theorized that Agrobacterium somehow triggered a developmental change in plants, resulting in the tumors associated with crown gall disease. Subsequently, at the University of Washington in Seattle, microbiologist Gene Nester, plant viral RNA biochemist Milt Gordon,

Written byPaula Park
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In the end, Braun accepted the new theory. "[Braun] said, 'Mary-Dell, you have convinced me there was DNA moving from the Agrobacterium into the plant,'" relates Andrew Binns, biology department head and Carolyn Hoff Lynch professor of biology at the University of Pennsylvania, who worked with Chilton. "He had to swallow that the previous 15 years of his work was incorrect. She was a good teacher."

Chilton, who left academia in the 1980s to join the private sector, has leaned on that teaching skill more often than she perhaps ever reckoned. As a pioneer in the science of transgenic plants, she is sometimes forced to defend her work to environmental groups, such as Greenpeace and Environmental Defense, who want to stem international trade in genetically engineered food crops. "I never envisioned that that could happen—the environmentalists' slap," she says. "I'm still astonished at that, I don't understand it."

In 1977, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies